BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19117981)

  • 1. Sequence variants at 22q13 are associated with prostate cancer risk.
    Sun J; Zheng SL; Wiklund F; Isaacs SD; Li G; Wiley KE; Kim ST; Zhu Y; Zhang Z; Hsu FC; Turner AR; Stattin P; Liu W; Kim JW; Duggan D; Carpten J; Isaacs W; Grönberg H; Xu J; Chang BL
    Cancer Res; 2009 Jan; 69(1):10-5. PubMed ID: 19117981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel prostate cancer susceptibility locus at 19q13.
    Hsu FC; Sun J; Wiklund F; Isaacs SD; Wiley KE; Purcell LD; Gao Z; Stattin P; Zhu Y; Kim ST; Zhang Z; Liu W; Chang BL; Walsh PC; Duggan D; Carpten JD; Isaacs WB; Grönberg H; Xu J; Zheng SL
    Cancer Res; 2009 Apr; 69(7):2720-3. PubMed ID: 19318570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germ-line sequence variants of PTEN do not have an important role in hereditary and non-hereditary prostate cancer susceptibility.
    Xie CC; Lu L; Sun J; Zheng SL; Isaacs WB; Gronberg H; Xu J
    J Hum Genet; 2011 Jul; 56(7):496-502. PubMed ID: 21633361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide copy-number variation analysis identifies common genetic variants at 20p13 associated with aggressiveness of prostate cancer.
    Jin G; Sun J; Liu W; Zhang Z; Chu LW; Kim ST; Sun J; Feng J; Duggan D; Carpten JD; Wiklund F; Grönberg H; Isaacs WB; Zheng SL; Xu J
    Carcinogenesis; 2011 Jul; 32(7):1057-62. PubMed ID: 21551127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.
    Duggan D; Zheng SL; Knowlton M; Benitez D; Dimitrov L; Wiklund F; Robbins C; Isaacs SD; Cheng Y; Li G; Sun J; Chang BL; Marovich L; Wiley KE; Bälter K; Stattin P; Adami HO; Gielzak M; Yan G; Sauvageot J; Liu W; Kim JW; Bleecker ER; Meyers DA; Trock BJ; Partin AW; Walsh PC; Isaacs WB; Grönberg H; Xu J; Carpten JD
    J Natl Cancer Inst; 2007 Dec; 99(24):1836-44. PubMed ID: 18073375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genome-wide survey over the ChIP-on-chip identified androgen receptor-binding genomic regions identifies a novel prostate cancer susceptibility locus at 12q13.13.
    Feng J; Sun J; Kim ST; Lu Y; Wang Z; Zhang Z; Gronberg H; Isaacs WB; Zheng SL; Xu J
    Cancer Epidemiol Biomarkers Prev; 2011 Nov; 20(11):2396-403. PubMed ID: 21960693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer.
    Liu W; Sun J; Li G; Zhu Y; Zhang S; Kim ST; Sun J; Wiklund F; Wiley K; Isaacs SD; Stattin P; Xu J; Duggan D; Carpten JD; Isaacs WB; Grönberg H; Zheng SL; Chang BL
    Cancer Res; 2009 Mar; 69(6):2176-9. PubMed ID: 19258504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations.
    Sun J; Chang BL; Isaacs SD; Wiley KE; Wiklund F; Stattin P; Duggan D; Carpten JD; Trock BJ; Partin AW; Walsh PC; Grönberg H; Xu J; Isaacs WB; Zheng SL
    Prostate; 2008 Sep; 68(12):1257-62. PubMed ID: 18491292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility.
    Lou H; Yeager M; Li H; Bosquet JG; Hayes RB; Orr N; Yu K; Hutchinson A; Jacobs KB; Kraft P; Wacholder S; Chatterjee N; Feigelson HS; Thun MJ; Diver WR; Albanes D; Virtamo J; Weinstein S; Ma J; Gaziano JM; Stampfer M; Schumacher FR; Giovannucci E; Cancel-Tassin G; Cussenot O; Valeri A; Andriole GL; Crawford ED; Anderson SK; Tucker M; Hoover RN; Fraumeni JF; Thomas G; Hunter DJ; Dean M; Chanock SJ
    Proc Natl Acad Sci U S A; 2009 May; 106(19):7933-8. PubMed ID: 19383797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.
    Tao S; Wang Z; Feng J; Hsu FC; Jin G; Kim ST; Zhang Z; Gronberg H; Zheng LS; Isaacs WB; Xu J; Sun J
    Carcinogenesis; 2012 Mar; 33(3):598-603. PubMed ID: 22219177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profile of common prostate cancer risk variants in an unscreened Romanian population.
    Iordache PD; Mates D; Gunnarsson B; Eggertsson HP; Sulem P; Guðmundsson J; Benónísdóttir S; Csiki IE; Rascu S; Radavoi D; Ursu R; Staicu C; Calota V; Voinoiu A; Jinga M; Rosoga G; Danau R; Sima SC; Badescu D; Suciu N; Radoi V; Manolescu A; Rafnar T; Halldórsson BV; Jinga V; Stefánsson K
    J Cell Mol Med; 2018 Mar; 22(3):1574-1582. PubMed ID: 29266682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium.
    Kote-Jarai Z; Easton DF; Stanford JL; Ostrander EA; Schleutker J; Ingles SA; Schaid D; Thibodeau S; Dörk T; Neal D; Donovan J; Hamdy F; Cox A; Maier C; Vogel W; Guy M; Muir K; Lophatananon A; Kedda MA; Spurdle A; Steginga S; John EM; Giles G; Hopper J; Chappuis PO; Hutter P; Foulkes WD; Hamel N; Salinas CA; Koopmeiners JS; Karyadi DM; Johanneson B; Wahlfors T; Tammela TL; Stern MC; Corral R; McDonnell SK; Schürmann P; Meyer A; Kuefer R; Leongamornlert DA; Tymrakiewicz M; Liu JF; O'Mara T; Gardiner RA; Aitken J; Joshi AD; Severi G; English DR; Southey M; Edwards SM; Al Olama AA; ; Eeles RA
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2052-61. PubMed ID: 18708398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
    Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
    J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replication of the 10q11 and Xp11 prostate cancer risk variants: results from a Utah pedigree-based study.
    Camp NJ; Farnham JM; Wong J; Christensen GB; Thomas A; Cannon-Albright LA
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1290-4. PubMed ID: 19336566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer.
    FitzGerald LM; Kwon EM; Conomos MP; Kolb S; Holt SK; Levine D; Feng Z; Ostrander EA; Stanford JL
    Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1196-203. PubMed ID: 21467234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine-mapping and family-based association analyses of prostate cancer risk variants at Xp11.
    Lu L; Sun J; Isaacs SD; Wiley KE; Smith S; Pruett K; Zhu Y; Zhang Z; Wiklund F; Grönberg H; Walsh PC; Chang BL; Zheng SL; Isaacs WB; Xu J
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2132-6. PubMed ID: 19549809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide two-locus epistasis scans in prostate cancer using two European populations.
    Tao S; Feng J; Webster T; Jin G; Hsu FC; Chen SH; Kim ST; Wang Z; Zhang Z; Zheng SL; Isaacs WB; Xu J; Sun J
    Hum Genet; 2012 Jul; 131(7):1225-34. PubMed ID: 22367438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.
    Xu J; Zheng SL; Isaacs SD; Wiley KE; Wiklund F; Sun J; Kader AK; Li G; Purcell LD; Kim ST; Hsu FC; Stattin P; Hugosson J; Adolfsson J; Walsh PC; Trent JM; Duggan D; Carpten J; Grönberg H; Isaacs WB
    Proc Natl Acad Sci U S A; 2010 Feb; 107(5):2136-40. PubMed ID: 20080650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.
    Yodsurang V; Tang Y; Takahashi Y; Tanikawa C; Kamatani Y; Takahashi A; Momozawa Y; Fuse N; Sugawara J; Shimizu A; Fukushima A; Hishida A; Furusyo N; Naito M; Wakai K; Yamaji T; Sawada N; Iwasaki M; Tsugane S; Hirata M; Murakami Y; Kubo M; Matsuda K
    PLoS One; 2018; 13(12):e0209096. PubMed ID: 30557369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk.
    Chang BL; Cramer SD; Wiklund F; Isaacs SD; Stevens VL; Sun J; Smith S; Pruett K; Romero LM; Wiley KE; Kim ST; Zhu Y; Zhang Z; Hsu FC; Turner AR; Adolfsson J; Liu W; Kim JW; Duggan D; Carpten J; Zheng SL; Rodriguez C; Isaacs WB; Grönberg H; Xu J
    Hum Mol Genet; 2009 Apr; 18(7):1368-75. PubMed ID: 19153072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.